Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.

Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K.

Thyroid. 2002 Mar;12(3):223-7.

PMID:
11952043
2.

[The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].

Wu T, Tang DR, Wang F, Xia S, Sun FY.

Zhonghua Yan Ke Za Zhi. 2017 Jun 11;53(6):430-435. doi: 10.3760/cma.j.issn.0412-4081.2017.06.007. Chinese.

PMID:
28606264
3.

Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease.

Lennerstrand G, Tian S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, Schworm H.

Acta Ophthalmol Scand. 2007 Mar;85(2):192-201.

4.

Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.

Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S.

J Clin Endocrinol Metab. 1995 Sep;80(9):2830-3.

PMID:
7673432
5.

Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.

Nagy EV, Toth J, Kaldi I, Damjanovich J, Mezosi E, Lenkey A, Toth L, Szabo J, Karanyi Z, Leovey A.

Eur J Endocrinol. 2000 Jun;142(6):591-7.

6.
7.

Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.

Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, Nonaka K, Nishimura H, Nishida H.

Thyroid. 1992 Winter;2(4):299-305.

PMID:
1493371
8.

The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.

Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM.

Clin Endocrinol (Oxf). 2001 Feb;54(2):205-9.

PMID:
11207635
9.

Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg.

Politi LS, Godi C, Cammarata G, Ambrosi A, Iadanza A, Lanzi R, Falini A, Bianchi Marzoli S.

Eur Radiol. 2014 May;24(5):1118-26. doi: 10.1007/s00330-014-3103-3. Epub 2014 Feb 12.

PMID:
24519110
10.

Magnetic Resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles.

Majos A, Pajak M, Grzelak P, Stefańczyk L.

Med Sci Monit. 2007 May;13 Suppl 1:44-8.

PMID:
17507884
11.

Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.

Han JS, Seo HS, Lee YH, Lee H, Suh SI, Jeong EK, Sapkota N, Kim KJ.

Neuroradiology. 2016 Dec;58(12):1189-1196. Epub 2016 Nov 14.

PMID:
27844093
12.

Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.

Jiang H, Wang Z, Xian J, Li J, Chen Q, Ai L.

Acta Radiol. 2012 Feb 1;53(1):87-94. doi: 10.1258/ar.2011.110431. Epub 2011 Dec 7.

PMID:
22184678
13.

Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.

Ben Simon GJ, Syed HM, Douglas R, McCann JD, Goldberg RA.

Am J Ophthalmol. 2004 Jun;137(6):1145-7.

PMID:
15183812
14.

[Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].

Sillaire I, Ravel A, Dalens H, Garcier JM, Boyer L.

J Radiol. 2003 Feb;84(2 Pt 1):139-42. French.

15.

Adhesion molecule expression in vivo on extraocular muscles (EOM) in thyroid-associated ophthalmopathy (TAO).

Pappa A, Calder V, Fells P, Lightman S.

Clin Exp Immunol. 1997 May;108(2):309-13.

16.

[Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].

Hosten N, Cordes M, Sander B, Schörner W, Wenzel KW, Felix R.

Rofo. 1990 Apr;152(4):388-92. German.

PMID:
2160096
17.
18.

Long-term multidisciplinary follow-up of unilateral thyroid-associated orbitopathy.

Daumerie Ch, Duprez T, Boschi A.

Eur J Intern Med. 2008 Nov;19(7):531-6. doi: 10.1016/j.ejim.2008.01.013. Epub 2008 Mar 18.

PMID:
19013383
19.

Determinants of extraocular muscle volume in patients with graves' disease.

El-Kaissi S, Wall JR.

J Thyroid Res. 2012;2012:368536. doi: 10.1155/2012/368536. Epub 2012 Feb 15.

20.

T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy.

Pappa A, Lawson JM, Calder V, Fells P, Lightman S.

Br J Ophthalmol. 2000 May;84(5):517-22.

Supplemental Content

Support Center